MICCAI 2016 Daily - Tuesday

MICCAI Daily: Where do you work, Sophie? Sophie: My name is Sophie Giffard- Roisin. I’m working as a PhD student in the Asclepios Research Project team which is in Sophia Antipolis in France, in INRIA. I work at a European Project called VP2HF which deals with cardiac resynchronization therapy. We are trying to know when the patients could be better implanted. Many are implanted, seeing a worsening of their situation. MICCAI Daily: Why does it happen? Sophie: Actually, at the moment, we don’t know when the patient will need the therapy or not. The clinicians need tools from us in order to know which patient will need the therapy. MICCAI Daily: What new information do you provide to the doctor to help them make this decision? Sophie: We model patient specific hearts, electric and mechanic. After that, we are able to simulate the therapy and help the clinician determining whether it will be beneficial for this patient or not. MICCAI Daily: How do you know? Do you have tests? Sophie: Yes, we are on the way to conducting clinical tests at the moment. This year is the end of the project. We have a new patient coming every two weeks in King’s College in London. That’s 50 patients, or we hope 100, in total. We are part of the project of modeling. We are dealing with the electric parts. MICCAI Daily: What challenges do you encounter in doing that work? Sophie: It’s difficult, because it’s an ill-posed problem: any small errors means high error at the end. We know it’s not easy to solve. In order to solve that, we have to constrain the problem because otherwise it is not feasible. CVPR Daily: Thursday Presentation 18 MICCAI Daily: Tuesday Estimation of Purkinje Activation From 12-Lead ECG: an Intermittent Left Bundle Branch Block Study Sophie Giffard-Roisin